GlassScriptPhysician profile
Billy R Morgan
NPI 1891747663
$121,561.69
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,330 · 2020: $8,692 · 2021: $7,074 · 2022: $10K · 2023: $54K · 2024: $37K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $74K · Education: $9,000 · Travel and Lodging: $5,337 · Food and Beverage: $2,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $74,450.00 |
| Education | $9,000.00 |
| Travel and Lodging | $5,337.21 |
| Food and Beverage | $2,412.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $90,701.74 | 2022-2024 | Andexxa |
| Portola Pharmaceuticals, LLC | $12,880.77 | 2019-2020 | |
| Intuitive Surgical, INC. | $9,153.25 | 2024 | |
| Alexion Pharmaceuticals, INC. | $7,820.35 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $469.61 | 2022 | |
| Prytime Medical Devices, INC. | $283.97 | 2021 | |
| Solventum Corporation | $110.52 | 2024 | Prevena |
| Kci USA, INC. | $82.43 | 2019 | |
| Z-Medica, LLC | $43.51 | 2020 | |
| Advanced Respiratory, INC | $15.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Billy Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.